Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Sherry Shen, MD
CONTACT
Tiffany Trainia, MD
CONTACT
Lead
Memorial Sloan Kettering Cancer Center
With
The study includes a safety run-in period in which the first 15 patients enrolled will be assigned to receive the study drug SDX-7320 in combination with eribulin. Upon safety confirmation, randomization will commence for the subsequent 40 patients enrolled.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted